Guangzhou Pharma Hopes To Revitalize TCM Industry With Genome Project
This article was originally published in PharmAsia News
Executive Summary
Many experts view the sequencing of the first medicinal plant genome as an indication that the genomic era will revitalize R&D in the Chinese medicine industry